Decreased cardiac sarcoplasmic reticulum Ca2+ -ATPase activity contributes to cardiac dysfunction in

Xiao-Yan Zhao1, Shen-Jiang Hu, Jiang Li

  • 1Institute of Cardiology, The First Affiliated Hospital, China.

Insights

Diabetic cardiomyopathy involves impaired heart muscle function. This study found reduced sarcoplasmic reticulum Ca2+-ATPase activity and cardiac dysfunction in diabetic rats, linked to increased phospholamban levels.

Area of Science:

  • Cardiology
  • Endocrinology
  • Molecular Biology

Background:

  • Diabetic cardiomyopathy is a distinct cardiac complication of diabetes mellitus.
  • It is characterized by impaired myocardial contractility, independent of vascular disease.
  • Sarcoplasmic reticulum Ca2+-ATPase (SERCA) plays a crucial role in cardiac muscle relaxation and contraction.

Purpose of the Study:

  • To investigate the alterations in cardiac sarcoplasmic reticulum Ca2+-ATPase activity and cardiac function in streptozotocin-induced diabetic rats.
  • To determine the role of phospholamban in the pathogenesis of diabetic cardiomyopathy.

Main Methods:

  • Diabetes mellitus was induced in male Wistar rats using streptozotocin.
  • Cardiac function was assessed by measuring left ventricular hemodynamic parameters (LVEDP, LVSP, +/- dP/dtmax).
  • Sarcoplasmic reticulum Ca2+-ATPase activity, phospholamban mRNA, and protein levels were quantified at 4, 6, and 8 weeks post-induction.

Main Results:

  • At 6 and 8 weeks, diabetic rats exhibited significantly decreased sarcoplasmic reticulum Ca2+-ATPase activity and impaired cardiac function.
  • Elevated phospholamban mRNA and protein levels were observed in diabetic rats at these time points.
  • No significant changes in sarcoplasmic reticulum Ca2+-ATPase protein levels were found, suggesting post-translational regulation or altered activity.

Conclusions:

  • Sarcoplasmic reticulum Ca2+-ATPase activity is depressed in streptozotocin-induced diabetic rats.
  • Increased phospholamban protein levels contribute to the pathogenesis of cardiac dysfunction in diabetic cardiomyopathy.
  • These findings highlight a key molecular mechanism underlying diabetic heart disease.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...